Please login to the form below

Not currently logged in
Email:
Password:

XenoGesis appoints business development consultant

Sabrina Mogle will spearhead CRO’s US growth

XenoGesis Sabrina MogleNottingham, UK-headquartered XenoGesis has appointed business development consultant Sabrina Mogle to drive the contract research organisation's growth in the US.

Bringing expertise in business and corporate development in the biotech and pharma industries, Mogle will spearhead XenoGesis' US business development strategy and industry awareness profile.

Richard Weaver, managing director of XenoGesis, said: “Sabrina's appointment supports our growth strategy to open up the US market. We already have a number of clients in the US and have identified the opportunity to grow our business further in the US.

“We are excited to welcome Sabrina to the team and her experience, knowledge and understanding of drug development and regulatory affair in the US will be a valuable addition to our business.”

Currently, Mogle serves as chief executive officer of RareMoon Consulting, a non-clinical development and regulatory affairs consulting firm specialising in orphan drugs she co-founded earlier this year.

She has previously held director-level roles at US biotechs NovusLife and Cote Orphan, and US CROs Toxikon Corporation and XenoTech.

Mogle said: “XenoGesis is an exciting, fast-growing and ambitious business and is developing an enviable reputation in the preclinical DMPK space for its consultative approach with clients.

“I am delighted to be part of the team and play my part in supporting the next stage growth.”

22nd September 2016

From: Research, Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...

Infographics